Allergan

After 21 Years and a Spinoff, Profitability Finally Arrives
Big Health Care Companies Are Undervalued
Botox Maker Allergan Sold to AbbVie for $63B
Proposals to Separate Joint CEO-Board Chair Roles Go Nowhere
Biotech CFO Pitches Fundamentals, not Financials
Allergan Buys CoolSculpting Company for $2.4B
Allergan Fined $15M Over Disclosure Failures
Allergan Bets on Tobira’s Liver Disease Drug
Pfizer Makes Cancer Play With Medivation Deal
Pfizer Adds Eczema Gel With $5B Anacor Deal
Finance Roundup for Executives
Did Treasury Target Pfizer-Allergan Inversion?
Clinton to Propose Crackdown on Inversions
Pfizer Buys Allergan for $160B
Activist Investor Can’t Dodge Insider Trading Suit